Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
American WellAMWL +0.17%50 9-Day RSI is 46.95 as of Aug. 25, 2026. GuruFocus rates AMWL with a GF Score™ of 50/100 and a GF Value™ of $6.42 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 697 Healthcare Providers & Services companies, American Well ranks better than 58.97% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-25), American Well's 9-Day RSI is 46.95.
The industry rank for American Well's 9-Day RSI or its related term are showing as below:
AMWL's 9-Day RSI is ranked better than 58.97% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 50.06
vs AMWL: 46.95
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
American Well 9-Day RSI Related Terms
AMWL vs LFMD, SY, HCAT: 9-Day RSI Comparison
For the Health Information Services subindustry, American Well's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Well 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, American Well's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where American Well's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Well (AMWL) has a 9-Day RSI of 46.95 as of Aug. 25, 2026. According to the industry distribution chart, American Well ranks #286 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 41%.
Is American Well's 9-Day RSI too high?
American Well's current 9-Day RSI is 46.95. The Healthcare Providers & Services industry median 9-Day RSI is 50.06. American Well's value of 46.95 is 6.2% below this industry median. Based on the distribution chart, American Well ranks #286 out of 697 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, American Well has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Well's 9-Day RSI compare to LFMD and SY?
According to the Healthcare Providers & Services industry distribution chart, American Well ranks #286 out of 697 companies for 9-Day RSI. This puts American Well in the upper half of its industry. The industry median 9-Day RSI is 50.06. American Well's value of 46.95 is 6.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.06, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Well's current 9-Day RSI of 46.95 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Well's current 9-Day RSI is 46.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Well stock overvalued right now?
Based on GuruFocus' analysis, American Well (AMWL) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.42, compared to a current price of $11.92 — trading 85.7% above its estimated fair value. The current 9-Day RSI is 46.95 and 6.2% below the Healthcare Providers & Services industry median of 50.06. American Well's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For American Well (AMWL), the current 9-Day RSI is 46.95 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is American Well (AMWL) Overvalued in 2026?
Based on GuruFocus' analysis, American Well stock appears to be overvalued.
The current stock price of $11.92 is trading 85.7% above its estimated GF Value™ of $6.42.
GuruFocus considers American Well to be Significantly Overvalued.
Key valuation signals for AMWL:
9-Day RSI: 46.95
GF Value™: $6.42 vs. price of $11.92 (85.7% above fair value)
Industry Position: 6.2% below the Healthcare Providers & Services median (#286 of 697)
No single metric tells the full story. See the AMWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
50GF Score
Get the complete analysis for AMWL
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMWL has been successfully added to your 
